title: Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
authors.forename: B
authors.initials: B
authors.lastname: Szelag
authors.forename: M
authors.initials: M
authors.lastname: Wroblewski
authors.forename: J
authors.initials: J
authors.lastname: Castenfors
authors.forename: M
authors.initials: M
authors.lastname: Henricsson
authors.forename: K
authors.initials: K
authors.lastname: Berntorp
authors.forename: P
authors.initials: P
authors.lastname: Fernlund
authors.forename: G
authors.initials: G
authors.lastname: Sundkvist
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000209:etiology / Q000503:physiopathology*; D001342:Autonomic Nervous System Diseases / Q000453:epidemiology* / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology / Q000503:physiopathology*; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology*; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D015995:Prevalence; D013548:Sweden / Q000453:epidemiology
chemical_list: D017395:Plasminogen Activator Inhibitor 1